Keywords: cephalon, sees, 4th-qtr, losses, hit, 9m, usa-based

Cephalon sees 4th-qtr losses hit $4.9M

Article | 19 February 2007

Print This

USA-based drug developer Cephalon says that, for the fourth quarter of 2006, it saw losses of $4.9 million, or $0.08 per share, compared ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in